NASDAQ:XAGE Longevity Health (XAGE) Stock Price, News & Analysis $0.21 -0.01 (-5.83%) As of 09/4/2026 11:26 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About Longevity Health Stock (NASDAQ:XAGE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Longevity Health alerts:Sign Up Key Stats Today's Range$0.21▼$0.2250-Day Range$0.21▼$0.3452-Week Range$0.21▼$2.80Volume16,067 shsAverage Volume2,596 shsMarket Capitalization$374.22 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania. Read More Receive XAGE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Longevity Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XAGE Stock News HeadlinesLongevity Health (NASDAQ:XAGE) Shares Down 5.8% - What's Next?September 5 at 2:01 AM | americanbankingnews.comLongevity Health Raises Capital via Secured Convertible NoteSeptember 4 at 5:51 PM | tipranks.comThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade. This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan.September 6 at 1:00 AM | Base Camp Trading (Ad)Longevity Health Holdings Announces Settlement of Litigation with Puritan Partners LLCAugust 17, 2026 | globenewswire.comLongevity Health Announces Routine Board Member ResignationJune 4, 2026 | tipranks.comLongevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused GrowthMarch 17, 2026 | globenewswire.comLongevity Health Holdings Ends Merger with True HealthDecember 12, 2025 | tipranks.comWhy Longevity Health Stock Is Skyrocketing TodayJuly 15, 2025 | benzinga.comSee More Headlines XAGE Stock Analysis - Frequently Asked Questions How have XAGE shares performed this year? Longevity Health's stock was trading at $0.3009 at the beginning of 2026. Since then, XAGE shares have decreased by 30.2% and is now trading at $0.21. How were Longevity Health's earnings last quarter? Longevity Health Holdings, Inc. (NASDAQ:XAGE) posted its quarterly earnings data on Thursday, August, 14th. The company reported ($1.56) earnings per share (EPS) for the quarter. The company had revenue of $0.50 million for the quarter. How do I buy shares of Longevity Health? Shares of XAGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/14/2025Today9/06/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:XAGE CIK1842939 Webwww.carmellrx.com Phone(412) 894-8248FaxN/AEmployees14Year FoundedN/AProfitability EPS (Trailing Twelve Months)($3.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.37 million Net Margins-682.67% Pretax Margin-691.89% Return on EquityN/A Return on Assets-261.90% Debt Debt-to-Equity RatioN/A Current Ratio0.47 Quick Ratio0.30 Sales & Book Value Annual Sales$1.05 million Price / Sales0.36 Cash FlowN/A Price / Cash FlowN/A Book Value($6.77) per share Price / Book-0.03Miscellaneous Outstanding Shares1,782,000Free Float1,265,000Market Cap$374.22 thousand OptionableN/A Beta0.40 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:XAGE) was last updated on 9/6/2026 by MarketBeat.com Staff. From Our PartnersThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredA New Approach to Retirement Income That Needs Less CapitalThe secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longevity Health Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longevity Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
